Apellis Pharmaceuticals, Inc. — Investor Relations & Filings
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company focused on developing therapies for a broad range of debilitating diseases by targeting the complement cascade. The company's scientific approach is centered on controlling C3, a central protein in this part of the immune system, to treat conditions driven by its overactivation. Apellis's development efforts are concentrated in the areas of ophthalmology, hematology, and nephrology. Its portfolio of approved medicines includes SYFOVRE® (pegcetacoplan injection) for the treatment of geographic atrophy (GA) and EMPAVELI® (pegcetacoplan) for other serious, complement-driven diseases.
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46022102 | S-8 POS | 2026-05-14 | English | ||
| 46022136 | S-8 POS | 2026-05-14 | English | ||
| 46026231 | S-8 POS | 2026-05-14 | English | ||
| 46022113 | S-8 POS | 2026-05-14 | English | ||
| 46026237 | S-8 POS | 2026-05-14 | English | ||
| 46022107 | S-8 POS | 2026-05-14 | English | ||
| 46028773 | S-8 POS | 2026-05-14 | English | ||
| 46026220 | S-8 POS | 2026-05-14 | English | ||
| 46026218 | S-8 POS | 2026-05-14 | English | ||
| 46028763 | S-8 POS | 2026-05-14 | English | ||
| 46012496 | 8-K | 2026-05-14 | English | ||
| 42821509 | 10-Q - Apellis Pharmaceuticals, Inc. (0001492422) (Filer) | 2026-05-07 | English | ||
| 40872205 | 8-K - Apellis Pharmaceuticals, Inc. (0001492422) (Filer) | 2026-05-04 | English | ||
| 32892669 | 4 - APELLIS PHARMACEUTICALS, INC. (0001492422) (Filer) | 2026-03-03 | English | ||
| 32892671 | 8-K - APELLIS PHARMACEUTICALS, INC. (0001492422) (Filer) | 2026-03-02 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Apellis Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31417/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31417 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31417 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31417 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31417}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Apellis Pharmaceuticals, Inc. (id: 31417)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.